Formulated Fibrillar Collagen (2.6%) Wound Conforming Matrix

Formulated Fibrillar Collagen (2.6%) Wound Conforming Matrix

 

A 3-dimensional wound conforming matrix that immediately activates platelets to accelerate healing in acute and chronic wounds

 
 

Product Description

Excellagen is for use by healthcare professionals in the United States.
Excellagen Activates Platelets Triggering Release of PDGF Key Wound Healing Growth Factors. (US Patent issued 10/7/20172017)

Excellagen Activates Platelets Triggering Release of PDGF Key Wound Healing Growth Factors. (US Patent issued 10/7/20172017)

  • Excellagen is an FDA- 510(k) cleared aseptically-manufactured, syringe-based, ready to use 3-dimensional wound conforming matrix that supports a favorable wound healing environment.

  • It is designed to accelerate granulation tissue growth by providing a structural scaffold for cellular migration and proliferation, and activates platelets, triggering the localized release of endogenous growth factors including Platelet-Derived Growth Factor (PDGF), a key biological mediator of wound healing.

INDICATIONS FOR USE:
Excellagen is indicated for the management of wounds including: partial and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (donor sites/graft, post-Mohs surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second-degree burns and skin tears) and draining wounds.

Excellagen should not be used in individuals with a known sensitivity to bovine collagen.

excellagen_07340_sm.jpg